One in four hepatitis C patients denied initial approval for drug treatment

Nearly one in four patients with chronic hepatitis C are denied initial approval for a drug therapy that treats the most common strain of the infection.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1UmHQSj